(RWAY) Runway Growth Finance - Overview

Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 250m USD | Total Return: -12% in 12m

Growth Capital, Senior Loans, Technology, Healthcare, Software
Total Rating 24
Safety 69
Buy Signal -0.75
Asset Management
Industry Rotation: +5.5
Market Cap: 250M
Avg Turnover: 3.62M USD
ATR: 3.61%
Peers RS (IBD): 12.3
Risk 5d forecast
Volatility26.9%
Rel. Tail Risk-3.10%
Reward TTM
Sharpe Ratio-0.83
Alpha-40.72
Character TTM
Beta0.565
Beta Downside0.961
Drawdowns 3y
Max DD34.83%
CAGR/Max DD-0.11
EPS (Earnings per Share) EPS (Earnings per Share) of RWAY over the last years for every Quarter: "2021-03": 0.3, "2021-06": 0.35, "2021-09": 0.32, "2021-12": 0.28, "2022-03": 0.3, "2022-06": 0.35, "2022-09": 0.36, "2022-12": 0.45, "2023-03": 0.45, "2023-06": 0.49, "2023-09": 0.54, "2023-12": 0.45, "2024-03": 0.46, "2024-06": 0.37, "2024-09": 0.41, "2024-12": 0.39, "2025-03": 0.42, "2025-06": 0.45, "2025-09": 0.43, "2025-12": 0.32, "2026-03": 0,
EPS CAGR: -44.72%
EPS Trend: -43.7%
Last SUE: -4.00
Qual. Beats: 0
Revenue Revenue of RWAY over the last years for every Quarter: 2021-03: 11.267456, 2021-06: 9.003824, 2021-09: 13.111863, 2021-12: 20.881583, 2022-03: 5.722, 2022-06: 3.246, 2022-09: 17.569, 2022-12: 28.951834, 2023-03: 24.526, 2023-06: 35.282, 2023-09: 26.752, 2023-12: 7.958, 2024-03: 24.772, 2024-06: 20.298, 2024-09: 37.99, 2024-12: 41.157, 2025-03: 13.727, 2025-06: 30.529, 2025-09: 20.992, 2025-12: 29.657, 2026-03: null,
Rev. CAGR: 55.08%
Rev. Trend: 52.4%
Last SUE: 0.06
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: RWAY Runway Growth Finance

Runway Growth Finance Corp. (RWAY) operates as a business development company (BDC).

The company focuses on providing senior-secured loans to late-stage and growth companies. BDCs are regulated investment companies that invest in small and mid-sized businesses.

RWAY targets specific sectors, including technology, life sciences, healthcare, information services, and select consumer services. Its investment size for senior secured loans ranges from $10 million to $75 million.

For more detailed financial analysis, consider exploring ValueRay.

Headlines to Watch Out For
  • Technology and life sciences loan demand drives revenue
  • Interest rate fluctuations impact net investment income
  • Credit quality of portfolio companies affects profitability
  • Regulatory changes for BDCs create compliance costs
  • Economic downturns increase loan default risk
Piotroski VR‑10 (Strict) 4.0
Net Income: 34.0m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -4.76 > 1.0
NWC/Revenue: -4.79% < 20% (prev 4.95%; Δ -9.74% < -1%)
CFO/TA 0.03 > 3% & CFO 25.1m > Net Income 34.0m
Net Debt (431.7m) to EBITDA (76.7m): 5.63 < 3
Current Ratio: 0.85 > 1.5 & < 3
Outstanding Shares: last quarter (36.7m) vs 12m ago -2.05% < -2%
Gross Margin: 68.20% > 18% (prev 0.69%; Δ 6.75k% > 0.5%)
Asset Turnover: 9.25% > 50% (prev 11.38%; Δ -2.13% > 0%)
Interest Coverage Ratio: 0.61 > 6 (EBITDA TTM 76.7m / Interest Expense TTM 42.7m)
Altman Z'' -0.14
A: -0.00 (Total Current Assets 25.8m - Total Current Liabilities 30.3m) / Total Assets 960.1m
B: -0.05 (Retained Earnings -49.9m / Total Assets 960.1m)
C: 0.03 (EBIT TTM 25.9m / Avg Total Assets 1.03b)
D: -0.10 (Book Value of Equity -49.5m / Total Liabilities 475.1m)
Altman-Z'' Score: -0.14 = B
What is the price of RWAY shares? As of April 08, 2026, the stock is trading at USD 6.72 with a total of 467,921 shares traded.
Over the past week, the price has changed by -2.18%, over one month by -10.99%, over three months by -23.10% and over the past year by -11.96%.
Is RWAY a buy, sell or hold? Runway Growth Finance has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold RWAY.
  • StrongBuy: 3
  • Buy: 0
  • Hold: 6
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the RWAY price?
Analysts Target Price 9.2 37.1%
Runway Growth Finance (RWAY) - Fundamental Data Overview as of 08 April 2026
P/E Trailing = 7.4301
P/E Forward = 5.2798
P/S = 1.8182
P/B = 0.5134
P/EG = 1.1571
Revenue TTM = 94.9m USD
EBIT TTM = 25.9m USD
EBITDA TTM = 76.7m USD
 Long Term Debt = unknown (none)
 Short Term Debt = unknown (none)
 Debt = 449.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 431.7m USD (from netDebt column, last quarter)
Enterprise Value = 681.4m USD (249.7m + Debt 449.9m - CCE 18.2m)
Interest Coverage Ratio = 0.61 (Ebit TTM 25.9m / Interest Expense TTM 42.7m)
EV/FCF = 11.63x (Enterprise Value 681.4m / FCF TTM 58.6m)
FCF Yield = 8.60% (FCF TTM 58.6m / Enterprise Value 681.4m)
FCF Margin = 61.72% (FCF TTM 58.6m / Revenue TTM 94.9m)
Net Margin = 35.88% (Net Income TTM 34.0m / Revenue TTM 94.9m)
Gross Margin = 68.20% ((Revenue TTM 94.9m - Cost of Revenue TTM 30.2m) / Revenue TTM)
Gross Margin QoQ = 93.64% (prev 55.47%)
Tobins Q-Ratio = 0.71 (Enterprise Value 681.4m / Total Assets 960.1m)
Interest Expense / Debt = 3.20% (Interest Expense 14.4m / Debt 449.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 20.4m (EBIT 25.9m * (1 - 21.00%))
Current Ratio = 0.85 (Total Current Assets 25.8m / Total Current Liabilities 30.3m)
Debt / Equity = 0.93 (Debt 449.9m / totalStockholderEquity, last quarter 485.0m)
Debt / EBITDA = 5.63 (Net Debt 431.7m / EBITDA 76.7m)
Debt / FCF = 7.37 (Net Debt 431.7m / FCF TTM 58.6m)
Total Stockholder Equity = 494.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.32% (Net Income 34.0m / Total Assets 960.1m)
RoE = 6.89% (Net Income TTM 34.0m / Total Stockholder Equity 494.2m)
RoCE = 2.78% (EBIT 25.9m / Capital Employed (Total Assets 960.1m - Current Liab 30.3m))
RoIC = 2.11% (NOPAT 20.4m / Invested Capital 969.6m)
WACC = 4.47% (E(249.7m)/V(699.6m) * Re(7.97%) + D(449.9m)/V(699.6m) * Rd(3.20%) * (1-Tc(0.21)))
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.82%
[DCF] Terminal Value 80.82% ; FCFF base≈82.5m ; Y1≈54.2m ; Y5≈24.8m
[DCF] Fair Price = 9.82 (EV 786.7m - Net Debt 431.7m = Equity 354.9m / Shares 36.1m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -43.71 | EPS CAGR: -44.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: 52.40 | Revenue CAGR: 55.08% | SUE: 0.06 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.37 | Chg7d=-0.002 | Chg30d=-0.023 | Revisions Net=-3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.45 | Chg7d=-0.009 | Chg30d=-0.072 | Revisions Net=-5 | Growth EPS=-6.2% | Growth Revenue=+2.8%
EPS next Year (2027-12-31): EPS=1.49 | Chg7d=-0.040 | Chg30d=-0.100 | Revisions Net=-4 | Growth EPS=+2.2% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.5% (Discount Rate 8.0% - Earnings Yield 13.5%)
[Growth] Growth Spread = +5.2% (Analyst -0.3% - Implied -5.5%)
External Resources
Dataroma Stockcircle